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Abstract
Background: Hypertensive nephropathy is one of the major 
causes of ESRD. Exercise has been considered a nonpatho-
logical therapy for hypertension and its complications, yet 
mechanisms remain unclear. We sought to investigate 
whether periodic swimming could ameliorate hypertension-
induced kidney dysfunction and its underlying mechanisms. 
Methods: Four-week male spontaneously hypertensive rats 
(SHRs) were randomly divided into the hypertension group 
(SHR, n = 8) and exercise group (SE, n = 8, 60 min swimming/
day, 6 days per week, for 8 weeks). Wistar-Kyoto rats (WKY, 
n = 8) were served as a sedentary normotensive group. Body-
weight and blood pressure (BP) were recorded weekly. After 
8-week sedentary or swimming exercise, lipids profile, BUN, 
and Cr were measured. The renal interstitial fibrosis was ex-
amined by the histopathological analysis using Masson’s tri-
chrome staining and hematoxylin and eosin staining. The 
kidney cell apoptosis was tested by TUNEL staining. The ex-
pressions of critical proteins responsible for the TGF-β1/
Smad signaling of fibrosis, that is, TGF-β1, Smad2/3, and 
Smad7, as well as apoptosis related proteins, Bax and Bcl-2 
in kidney cortex tissues were measured. Results: The 8-week 
swimming exercise reduced BP and bodyweight, lowered 
concentrations of BUN, and serum Cr, compared with SHR. 
Exercise remarkably inhibited hypertension-induced tubular 
degeneration, cellular cluster, and tubular cell swelling as 
well as glomerular degeneration in the kidney cortical tis-
sues, attenuated renal interstitial fibrosis, and renal cell 
apoptosis. Moreover, expressions of TGF-β1, Smad2/3, and 
Bax were higher in the SHR than the WKY, which were sig-
nificantly suppressed by the exercise. In contrast, hyperten-
sion-reduced expressions of Smad7 and Bcl-2 were en-
hanced by the swimming exercise. Strong correlations were 
found between kidney function indices, blood lipids, and 
key protein expressions. Conclusion: Our results demon-
strate beneficial effects of the periodic swimming on amelio-
rating hypertension-induced kidney dysfunction highlight-
ing the potential of swimming exercise as a nonpathological 
therapy for early prevention of hypertension-caused kidney 
diseases. © 2021 The Author(s).
Published by S. Karger AG, Basel
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Introduction
The prevalence of hypertension is on the rise world-
wide, and hypertensive nephropathy is the second leading 
cause of ESRD. Accumulating evidence demonstrates as-
sociations between elevated blood pressure (BP) and risk 
of development or progression of several noncommuni-
cable diseases, including CKD [1, 2]. Exercise has been 
considered a nonpharmacological and effective treat-
ment to control BP [3–5] and its benefits greatly extend 
beyond the reduction of traditional cardiovascular risk 
factors [6, 7]. Several studies showed that appropriate ex-
ercise improves kidney function [8–10]. Yet, underlying 
mechanisms of how exercises could affect hypertension-
induced kidney dysfunction remain largely unexplored 
[11].
The renal interstitial fibrosis, characterized by an ex-
cess deposition of the extracellular matrix, has been pro-
posed as a common pathological hallmark of progressive 
CKD with diverse aetiologies [12, 13]. TGF-β is well 
known as a central pro-fibrotic mediator in renal fibrosis, 
by signaling through the downstream receptor-associat-
ed Smads, including Smad2, Smad3, and Smad7 to exert 
its biological activities on different types of kidney cells 
during renal fibrosis [14–16]. In a recent study, Huang et 
al. [17] found that exercise training (i.e., running for 60 
min/day, 5 sessions/week, and for 12 weeks) might ame-
liorate renal abnormalities in hypertensive rats through 
the downregulation of the TGF-β and p-Smad2/3 path-
way. However, these receptor-associated Smads have dif-
ferent or even contradictorily impacts on regulating renal 
fibrosis [12, 14, 16], highlighting the need to have a com-
prehensive understanding how exercise could influence 
expression of different receptor-associated Smads.
Abnormal expression of TGF-β and its family mem-
bers may lead to endoplasmic reticulum stress and oxida-
tive stress and subsequently result in renal cell injury and 
fibrosis that contribute to progressively renal dysfunction 
[18–20]. The renal cell apoptosis is an important factor in 
the pathogenesis of CKD, which could be induced by both 
excessive endoplasmic reticulum stress and oxidative 
stress in varying renal cell types [18, 19, 21–23] [18, 19, 
21, 23]. Moreover, the renal cell apoptosis has shown 
strong links with the process of kidney interstitial fibrosis. 
Chen et al. [24] reported that treadmill running exercise 
(i.e., 3 times per week, for a total period of 11 weeks) ame-
liorated doxorubicin-induced CKD particularly through 
the regulation of the apoptosis pathways.
In this study, we aimed to investigate whether peri-
odic swimming could alleviate impairment of kidney 
structure and function caused by hypertension, possibly 
via beneficial impacts on the TGF-β1/Smad signaling and 
renal cell apoptosis. It may provide a new perspective to 
understand mechanisms underlying benefits of exercise 
in ameliorating hypertension-induced renal damage and 




Four-week male Wistar-Kyoto rats (WKY, n = 8) and sponta-
neously hypertensive rats (SHRs, n = 16) were purchased from 
Beijing Vital River Laboratory Animal Technology Co. Ltd. (the 
license number: SCXK [Beijing] 2016-0006, MHC Haplotype: 
RT1k). SHR is the most widely studied animal model of hyperten-
sion [25–27]. All rats were housed under constant room tempera-
ture (22°C ± 1°C), humidity (60 ± 5%), and 12-h dark/light cycles, 
with free access to tap water and standard rat chow (Xietong shen-
wu, Jiangsu, China). The production standard of the standard 
chow refers to the standard of Jackson experiment of USA. The 
contents of nutrients are provided in the online suppl. Table 1 (see 
www.karger.com/doi/10.1159/000514680 for all online suppl. ma-
terial).
Exercise Training Protocol
SHRs were randomly divided into the hypertension group (n = 
8) and exercise group (SE, n = 8). Exercise training was performed 
in the animal tank with heated water (30 ± 1°C) for 9 weeks. The 
first week consisted of an adaptation period, initiated with 10 min 
of continuous swimming training on the first day. Swimming time 
was increased daily until reached to 60 min at the end of the pro-
tocol. The formal training began from the second week, and the 
exercise duration was kept constant (60 min/day, 6 days/week). It 
was maintained until the end of the training period, which lasted 
8 weeks. To avoid the occurrence of acute exercise-related errors, 
animals rested for 48 h before being sacrificed for all additional 
procedures.
Assessments of Bodyweight, Blood Pressure, and Heart Rate
After 1-week adaptive feeding, bodyweight (BW) of each rat 
was measured weekly. Systolic (SBP)/diastolic blood pressure, 
mean arterial pressure (MAP), and the heart rate (HR) were evalu-
ated in conscious rats before the training period. We applied an 
indirect tail-cuff method for BP analysis, conditioned to the pro-
cedure with cuff inflation-deflation cycles until the end of the ex-
ercise training protocol, using the CODATM mouse rat tail-cuff sys-
tem (Kent Scientific Corporation, Torrington, CT, USA).
Blood Collection and Biochemical Parameters Analyses
Rats were anesthetized with pentobarbital sodium and sacrificed 
by decapitation. Blood samples were collected from the abdominal 
aorta and put into water bath (37°C) for 30 min. The serum was 
obtained by centrifugation (12,000 g, 20 min) and stored under 
−80°C until analyses. Concentrations of BUN, serum Cr (SCr), to-
tal cholesterol (TC), total triglycerides (TG), high-density lipopro-
tein cholesterol (HDL-C), and low-density lipoprotein cholesterol 
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(LDL-C) were assayed with the corresponding kits provided by 
Nanjing Jiancheng Bioengineering Institute (Nanjing, China) fol-
lowing the manufacturer’s instruction.
Tissue Collection
After euthanization, kidneys were immediately divided into 2 
parts: one part was stored in 10% formaldehyde for histopatho-
logical analysis; the other part was frozen with liquid nitrogen and 
was stored at −80°C.
Histologic Analysis
Kidney tissues were fixed by immersion with 10% formalde-
hyde at 4°C for 24 h and processed for paraffin embedding. After 
dehydration and embedding, tissues were sliced into 5-µm paraffin 
sections for hematoxylin and eosin staining and Masson staining. 
The renal cortex and medulla were not separated during the dis-
section. This procedure could protect the kidney morphology as 
much as possible during the dehydration and embedding process, 
which is beneficial to histopathological experiments [28]. Finally, 
all sections were visualized using an Olympus light microscope 
(CX31, Tokyo, Japan). Selected portions were randomly scanned, 
and quantitative analysis was performed using an Image-Pro Plus 
(Media Cybernetics, Rockville, MD, USA) analysis system at ×400 
magnification.
TUNEL Staining
A terminal deoxynucleotidyl transferase-mediated biotinylat-
ed UTP nick end labeling (TUNEL) reaction was carried out ac-
cording to the manufacturer’s instruction. Paraffin-embedded sec-
tions were cut to 5-µm thicknesses, followed by conventional de-
waxing and rehydration. Prior to the test with TUNEL Apoptosis 
Assay Kit (Seven Sea Biotech Company, Guangzhou, China), sec-
tions were incubated with Proteinase K to increase permeability. 
Subsequently, they were scanned randomly and visualized using 
an Olympus inverted fluorescence microscope (IX73, Tokyo, Ja-
pan) in the darkroom.
Western Blotting
Frozen kidney cortex tissues (approximately 50 mg at −80°C) 
were homogenized with 1 mL of Pro-PREP lysis buffer and 1 mL 
protease inhibitor (Beyotime Company, Shanghai, China) in a ho-
mogenizer (Proteintech, China). The homogenate was centrifuged 
at 12,000 g for 20 min at 4°C, and the supernatant was collected as 
tissue sample protein, and the concentrate was determined using 
a bicinchoninic acid assay kit (Proteintech, China). Then, the sam-
ple was heated at 100°C for 10 min before loading and separated 
on precast 10% SDS-PAGE to electrophoresis. Twenty µg total 
protein was loaded into a single well of a 10–12% polyacrylamide 
gel for electrophoretic separation and subsequently transferred 
onto a polyvinylidene difluoride membrane (Millipore, German). 
The nonspecific binding to the membrane was blocked with 5% 
nonfat milk in TBS buffer for 1 h at room temperature. The mem-
branes were then incubated for 16 h at 4°C with primary antibody: 
rabbit monoclonal anti-Smad2/3 antibody (Abcam, ab202445, 
1:1,000), rabbit monoclonal antibody anti-Smad7 antibody (Bioss, 
bs-0566R, 1:500), rabbit polyclonal anti-TGF/β1 (Bioss, bs-0086R, 
1:500) antibody, rabbit monoclone anti-GAPDH antibody (Ab-
cam, ab181602, 1:1,000), Bcl-2 (Bioss, bsm-33411M), and Bax 
(Bioss, bs-0127R). After washing in TBST buffer for 5 times, the 
membranes were incubated for 1 h at room temperature with the 
HRP conjugated secondary antibody (Bioss, bs-0566R, bs40295G, 
1:10,000) in blocking buffer containing 5% nonfat milk. The PVDF 
membranes were then washed with TBST buffer for 5 times, and 
SuperSignal West Femto Maximum Sensitivity Substrate (Thermo 
Fisher Scientific, Waltham, MA, USA) was used to detect the bands 
in a darkroom. The integrated optical density was measured by 
scanner. The sum of the integrated optical density was obtained, 
and the mean value calculated. Levels of TGF-β1, Smad-2/3, and 
Smad-7 were analyzed by Image-Pro Plus.
Statistics
Data are expressed as mean ± standard error of mean and ana-
lyzed using GraphPad prism 6.0 (GraphPad software, San Diego, 
CA, USA). Data were analyzed by using Student’s t test for com-
parison of 2 groups and by one-way ANOVA for multiple groups. 
A p value <0.05 was considered significant. Spearman rank corre-
lations between BW, BP, HR, BUN and SCr, blood lipids, and key 
proteins were computed. Heat map was drawn using MetaboAna-
lyst (www.metaboanalyst.ca).
Results
Effects of Swimming on Bodyweight, Blood Pressure, 
Heart Rate, and Blood Parameters
No significant difference in BW was observed between 
groups during the period 1–7 weeks (p > 0.05, shown in 
Fig. 1). In the eighth week, SHR showed significantly high-
Table 1. Effects of swimming exercise on blood lipids and renal function indices in SHRs
TC, mmol/L TG, mmol/L HDL-C, mmol/L LDL-C, mmol/L SCr, mmol/L BUN, mmol/L
WKY 1.86±0.11 0.54±0.02a 0.78±0.10 0.61±0.04a 37.39±1.58a 3.56±0.19a
SHR 1.93±0.04 0.62±0.23b 0.90±0.20 0.96±0.08b 71.88±2.23c 7.04±0.26c
SE 1.77±0.07 0.63±0.03b 0.73±0.12 0.68±0.08a 61.25±2.07b 5.87±0.29b
Different letters indicate significances. HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density 
lipoprotein cholesterol; SCr, serum Cr; SE, SHR exercise group; SHRs, spontaneously hypertensive rats; TC, total 
cholesterol; TG, total triglycerides; WKY, Wistar-Kyoto rats.
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er BW than WKY and SE. Blood pressure in general were 
higher in the SHR group than in the WKY group 
(p < 0.01). Swimming exercise reduced SBP, diastolic 
blood pressure, and MAP, and significant differences were 
seen at week 7–8 for SBP and week 6–8 for MAP between 
the SE group and the SHR group (p < 0.05). HR was lower 
after 8 weeks of swimming (342.0 ± 7.514 beats/min) than 
the SHR group (381.2 ± 10.21 beats/min (p < 0.01).
SHR had significantly higher levels of BUN and SCr 
than the WKY group (p < 0.05, Table 1). The swimming 
exercise substantially reduced levels of BUN and SCr 
compared with the SHR group. The serum TG and LDL-
C in the SHR group were raised to 0.62 and 0.96 mmol/L 
compared with the 0.54 and 0.61 mmol/L in the WKY. 
Swimming exercise ameliorated the level of LDL-C to 















Fig. 1. Effects of swimming exercise on the BW and BP in SHRs. Changes in BW (A), SBP (B), DBP (C), MBP (D), 
and HR (E) in each group during the exercise period. Data are presented with mean ± SEM (n = 8). BW, body-
weight; BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; MBP, mean blod pressure; 
HR, heart rate; SHRs, spontaneously hypertensive rats; SE, SHR exercise group; WKY, Wistar-Kyoto rats.
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Effects of Swimming on Pathologic Changes of Renal 
Tissues
Results from hematoxylin and eosin staining showed 
that there were prominent degenerative changes with tu-
bular degeneration, cellular cluster, and tubular cell swell-
ing as well as glomerular degeneration in the kidney cor-
tical tissues in the SHR group (shown in Fig. 2A). The 
swimming exercise decreased cellular cluster, and there 
was no obviously structural lesion in the SE group. The 
kidney tissue fibrosis which comes from the histopatho-
logic evaluation was assessed for the SHR, WKY, and SE 
groups by using Masson’s trichrome analysis. The renal 
cortex in the SHR group exhibited a larger area of fibrosis 
than the WKY group, which was significantly suppressed 
by swimming exercise (p < 0.01, shown in Fig. 2B, C).
Effects of Swimming on Expressions of Proteins 
Related with TGF-β1/Smad Signaling
The expressions of pro-fibrosis factors, including 
TGF-β1, Smad2/3, and p-Smad2/3, were higher in the 
SHR group than the WKY group (shown in Fig. 3, p < 















Fig. 2. Effects of swimming exercise on the renal interstitial fibrosis examined by using hematoxylin and eosin 
staining (A) and Masson’s trichrome staining (B), as well as on the area of interstitial fibrosis (C). ***p < 0.001. 
****p < 0.0001. SHRs, spontaneously hypertensive rats; SE, SHR exercise group; WKY, Wistar-Kyoto rats.
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cant reductions of TGF-β1 and Smad2/3 were observed 
in the SE group compared with the SHR group. On the 
contrary, Smad7 was elevated after swimming compared 
with the SHR group (p < 0.05).
Effects of Swimming on Renal Tubular Cell Apoptosis
Results from TUNEL staining of DNA damage showed 
that less apoptosis in the kidney tissue of the WKY group 
was observed than in the SHR group (shown in Fig. 4). 
Fig. 3. Effects of swimming on expressions of proteins related with TGF-β1/Smad signaling. p-Smad 2/3 (A); 
Smad 2/3 (B); Smad 7 (C); TGF-β1 (D). E Western blot of protein expressions. SHRs, spontaneously hypertensive 
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Fig. 4. Effects of swimming exercise on renal tubular cell apoptosis. A TUNEL staining of renal tubular cell apoptosis. 
The red arrows indicate the apoptotic cells. Effects of swimming on expressions of Bcl-2 (B) and Bax (C). D Western 
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Swimming alleviated apoptosis which was consistent 
with the Bax and Bcl-2 results. Specifically, we observed 
that swimming elevated the expression of Bcl-2 while in-
hibited the expression of Bax (shown in Fig. 4).
Correlations
Benefits of swimming exercise on BP control and kid-
ney protection were accomplished by the swimming-in-
duced favorable regulation of TGF-β1/Smad signaling as 
well as the pro-apototic and apoptotic parameters, that is, 
Bcl-2 and Bax expressions (shown in Fig. 5B). Significant 
correlations between BW, BP, HR, BUN, and SCr, blood 
lipids, and key proteins were observed (shown in Fig. 5A).
Discussion
Early implementation of protective interventions aim-
ing to ameliorate the decline in renal function prior to 
reaching end-stage renal failure holds great potential to 
decrease the incidence of CKD, thereby reducing mor-
bidity, mortality, and improving quality of life [29–31]. 
Our study reveals beneficial effects of 8-week swimming 
exercise on BP control, improving kidney function, alle-
viating renal interstitial fibrosis, and cell apoptosis in hy-
pertensive rats. Strong correlations between benefits of 
swimming on kidney protection, favorable regulation of 
TGF-β1/Smad signaling as well as the pro-apoptotic and 
apoptotic parameters, that is, Bcl-2 and Bax expressions, 
were observed. Our results provide compelling evidence 
on the protective effects of swimming exercise as a non-
invasive and effective therapy on the development of 
CKD caused by hypertension.
Persistent hypertension is often coupled with multiple 
target organ damages [32]. A worldwide epidemic of CKD 
exists, and hypertensive nephropathy is a vital cause for 
ESRD globally. Previous studies have suggested that aggres-
sive control of high BP, BW, and blood lipids, obtained 
through an appropriate therapeutic intervention, repre-
sents the key strategy to achieve a satisfactory prevention or 
management of the hypertension-induced kidney dysfunc-
tion [33]. Of note, our results showed that BW, BP, HR, and 
blood lipids, in particular, TG and LDL-C were effectively 
reduced by swimming exercise in hypertensive rats, which 
were associated with the exercise-induced reduction of 
BUN and SCr. Circulating levels of BUN and SCr have been 
validated as the reliable and easily accessible biologic mark-
er for detecting kidney injury [34, 35].
Fig. 5. Correlations between BW, BP, HR, BUN and SCr, blood lipids, and key proteins (A) and their clusters 
discriminating spontaneously hypertensive rats (SHR, n = 8), SHR exercise group (SE, n = 8), and the Wistar-
Kyoto rats (WKY, n = 8) (B). BW, bodyweight; BP, blood pressure; HR, heart rate; SCr, serum Cr; LDL-C, low-
density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TC, total cholesterol; TG, total 
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Moreover, we found hypertensive rats suffered renal 
interstitial fibrosis, indicated by deleterious changes with 
tubular degeneration, cellular cluster, and tubular cell 
swelling as well as glomerular degeneration in the kidney 
tissues, consisting with previous studies [11, 36]. Al-
though the mechanisms involving the pathogenesis of hy-
pertensive renal fibrosis are not fully understood, TGF-β 
has been demonstrated as a central pro-fibrotic mediator 
in renal fibrosis. Specifically, Smad2 and Smad3 are the 
key molecules mediating TGF-β1 activity leading to renal 
fibrosis [12]. On the contrary, Smad7 is the inhibitor of 
TGF-β1/Smad signaling, and the enrichment of Smad7 
has been suggested as a therapeutic agent for renal fibro-
sis in kidney diseases. We observed the 8-week swimming 
exercise successfully decreased cellular cluster, sup-
pressed area of renal fibrosis, and beneficially regulated 
expressions of Smad2, Smad3, and Smad7. These findings 
highlight that swimming exercise could be effective for 
early prevention and management of hypertensive ne-
phropathy through the suppression of renal fibrosis via 
regulating the TGF-β1/Smad signaling.
Besides, hypertension has been associated with endo-
thelial dysfunction, altered contractility, vascular remod-
eling, and oxidative stress. Both excessive endoplasmic 
reticulum stress and oxidative stress may contribute to 
renal apoptosis. In line with previous studies [37], our re-
sults have shown strong links between renal cell apoptosis 
and interstitial fibrosis in the kidney lesion, and under the 
condition of the injury, the functional cell transition from 
a normal morphology to an apoptotic or fibrotic pheno-
type could be activated. Most interestingly, we found that 
exercise reversed hypertension-induced elevation in the 
Bax/Bcl-2 ratio, while increasing Bcl-2 levels in the kid-
ney, supporting the protective effects of swimming exer-
cise against increased apoptosis [15, 24, 38–40].
It should be noted that the pathogenesis of hyperten-
sion-induced kidney disease is complex and may include 
several molecule alterations that have not been fully eluci-
dated. Although exercise has shown benefits in alleviating 
hypertension-induced kidney dysfunction, underlying 
mechanisms remain largely unexplored. Except for the 
TGFβ/Smad signaling pathway and renal cell apoptosis, 2 
essential and pathological hallmarks of progressive CKD 
that we particularly investigated in this study, the renin-
angiotensin-aldosterone system has also been closely relat-
ed to hypertensive nephropathy and cardiovascular diseas-
es and plays an important role in regulating BP [41–43]. 
Exercise may act as an inhibitor of the renin-angiotensin-
aldosterone system significantly and has shown to reduce 
circulating AngII levels in SHR models [43]. Comprehen-
sive analyses of molecule alterations are warranted aiming 
to improve understanding of beneficial effects of exercise 
on hypertension-induced kidney diseases.
Conclusion
The 8-week swimming exercise beneficially reduced 
BP, BW, HR, and biologic markers for kidney injury, that 
is, BUN and SCr, in hypertensive rats. Consistently, 
swimming exercise remarkably ameliorated tubular dis-
order, hypertension-induced renal interstitial fibrosis, 
and renal cell apoptosis, partly via favorably regulating 
the TGF-β1/Smad signaling and Bcl-2 family protein ex-
pressions that were largely involved in the mitochondrial 
apoptotic pathway. Our findings suggest that swimming 
exercise holds great promise to be an antihypertensive 
and renal protective treatment prior to reaching severe 
hypertension-induced renal failure.
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